MAXIMIZING ONCOLOGY RESEARCH WITH BUILT-IN KRAS ASSAY PROVIDERS AND RAS ASSAYS

while in the fast evolving area of oncology investigation, precise and successful mutation screening is critical for developing qualified therapies. The KRAS solutions System performs a pivotal part On this landscape by giving comprehensive remedies for KRAS mutation profiling and Evaluation. KRAS mutations, present in somewhere around 95% of RAS-c